11 patents currently held
27 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in May 2029. from the record
Of the 27 now held by other companies, 17 name Motorola Solutions Connectivity Inc. as their current owner, and 10 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
1
Ending by 2030
May 2029
Next term end
9
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Sep 2037 · High confidence
Also notable
Ends Apr 2035 · Medium confidence
Also notable
Ends Feb 2037 · High confidence
Training and Selection of Multiple Fraud Detection Models
US 10,628,826
The most cited patent in this portfolio, cited by 46 later US patents, top 5% of utility patents granted in 2020 in our data. Protection runs to 2037.
Package Structure and Manufacturing Method of Package Structure
US 10,256,180
Cited by 35 later US patents, top 10% of utility patents granted in 2019 in our data, and renewed at 2 of 3 maintenance windows. Protection runs to 2035.
Anomaly Detection in Groups of Transactions
US 10,510,078
Cited by 26 later US patents, top 10% of utility patents granted in 2019 in our data. Protection runs to 2037.
Formerly held, still cited
Notable
Ends Sep 2035 · Medium confidence
Cited by 5 later US patents, top 25% of utility patents granted in 2023 in our data. Protection runs to 2035.
now held by Intercept LLC
Also notable
Ends Feb 2034 · High confidence
Cited by 12 later US patents, top 25% of utility patents granted in 2019 in our data, and renewed at 2 of 3 maintenance windows. Protection runs to 2034. A terminal disclaimer caps this term to an earlier patent's.
now held by Motorola Solutions Connectivity, Inc.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due May 26, 2027The maintenance fee for Optimization of Fraud Detection Model in Real Time (US 10,489,786) comes due May 26, 2027. Unpaid by Nov 26, 2027, it lapses early.
- 2 fees due Jun 3 to 17, 2027 · next Jun 3
- 1 fee due Oct 21, 2027The maintenance fee for Training and Selection of Multiple Fraud Detection Models (US 10,628,826) comes due Oct 21, 2027. Unpaid by Apr 21, 2028, it lapses early.
Recent changes
- 1 term has ended since Aug 19, 2026
What they patent
The 5 largest of its 9 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Package Substrate Structure | 2 in force | to Apr 2035 |
| Method of Differentiating Mammalian Progenitor Cells into Insulin Producing Pancreatic Islet Cells | 2 in force | to Jun 2031 |
| Training and Selection of Multiple Fraud Detection Models | 1 in force | to Sep 2037 |
| Optimization of Fraud Detection Model in Real Time | 1 in force | to Jun 2037 |
| Exclusion of Nodes from Link Analysis | 1 in force | to Mar 2037 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,605,244 | Method of Differentiating Mammalian Progenitor Cells into Insulin Producing Pancreatic Islet Cells held by Vesta Therapeutics Inc. In force · High confidence | In force | High confidence | |
| US 8,877,497 | Method of Differentiating Mammalian Progenitor Cells into Insulin Producing Pancreatic Islet Cells held by Vesta Therapeutics Inc. Grace period ended · Low confidence | Grace period ended | Low confidence | |
| US 10,256,180 | Package Structure and Manufacturing Method of Package Structure held by Vesta Microsystem Co., Ltd. In force · Medium confidence | In force | Medium confidence | |
| US 9,451,694 | Package Substrate Structure held by Vesta Microsystem Co., Ltd. In force · High confidence | In force | High confidence | |
| US 9,910,581 | Video Scrolling held by Vesta Innovations, Inc. In force · High confidence | In force | High confidence | |
| US D923,385 | Pass Through Grilling Mechanism In force · High confidence | In force | High confidence | |
| US D923,997 | Pass Through Grilling Mechanism In force · High confidence | In force | High confidence | |
| US 10,510,078 | Anomaly Detection in Groups of Transactions In force · High confidence | In force | High confidence | |
| US 10,496,992 | Exclusion of Nodes from Link Analysis In force · High confidence | In force | High confidence | |
| US 10,489,786 | Optimization of Fraud Detection Model in Real Time In force · High confidence | In force | High confidence |
Also on record, not counted in the 11: 27 patents in force now held by others · 20 patents ended · 1 application pending · 21 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.